B. Powell

发表

Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC‐205/CD205‐positive mouse dendritic cells

R. Steinman, R. Lynch, Young‐Sun Kang, 2008, European journal of immunology.

Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague

R. Steinman, S. Mehandru, D. Dudziak, 2010, European journal of immunology.

The Case for Developing Consensus Standards for Research in Microbial Pathogenesis: Bacillus anthracis Toxins as an Example

M. McKee, T. Rudge, B. Bishop, 2009, Infection and Immunity.

Cell cycle arrest in Era GTPase mutants: a potential growth rate‐regulated checkpoint in Escherichia coli

J. Lupski, D. Court, R. Britton, 1998, Molecular microbiology.

CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.

P. Worsham, A. Krieg, R. Fast, 2009, Vaccine.

Control of ftsZ Expression, Cell Division, and Glutamine Metabolism in Luria-Bertani Medium by the Alarmone ppGpp in Escherichia coli

D. Court, B. Powell, 1998, Journal of bacteriology.

Hospital microbiomics: benchmarking from the first longitudinal study of microbiome dynamics among patient, staff and hospital habitats

B. Powell, 2017 .

Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli.

G. Carter, J. L. Fox, K. Mollison, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Analytical Control Strategy of Bacterial Subunit Vaccines

M. Nissum, M. Pizza, C. Magagnoli, 2015 .

COMMENTARY The Case for Developing Consensus Standards for Research in Microbial Pathogenesis: Bacillus anthracis Toxins as an Example (cid:1)

M. McKee, T. Rudge, B. Bishop, 2009 .

VirA, a coregulator of Ti-specified virulence genes, is phosphorylated in vitro.

C. Kado, P. Morel, Y. Huang, 1990, Journal of bacteriology.

Frontline : Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205 / CD 205-positive mouse dendritic cells

R. Steinman, R. Lynch, Young‐Sun Kang, 2008 .

In Vitro Intracellular Trafficking of Virulence Antigen during Infection by Yersinia pestis

G. Ruthel, S. Welkos, H. Hines, 2009, PloS one.

VALIDATION OF QUANTITATIVE ELISAs FOR MEASURING ANTI-YERSINIA PESTIS F1 AND V ANTIBODY CONCENTRATIONS IN NONHUMAN PRIMATE SERA

J. Brown, J. Adamovicz, B. Powell, 2012, Journal of immunoassay & immunochemistry.

ASSESSMENT OF A RECOMBINANT F1-V FUSION PROTEIN VACCINE INTENDED TO PROTECT CANADA LYNX (LYNX CANADENSIS) FROM PLAGUE

L. Wolfe, T. Shenk, T. Rocke, 2011, Journal of wildlife diseases.

Bex, the Bacillus subtilis Homolog of the Essential Escherichia coli GTPase Era, Is Required for Normal Cell Division and Spore Formation

D. Court, R. Simons, V. Chary, 2002, Journal of bacteriology.

Analysis of the rnc locus of Coxiella burnetii

D. Court, T. Hoover, B. Powell, 1994, Molecular microbiology.

Novel Proteins of the Phosphotransferase System Encoded within the rpoN Operon of Escherichia coli

D. Court, M. Saier, T. Inada, 1995, The Journal of Biological Chemistry.

Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens

J. Clements, A. Glynn, C. Roy, 2005, Infection and Immunity.

Rapid confirmation of single copy lambda prophage integration by PCR.

Y. Nakamura, D. Court, C. Turnbough, 1994, Nucleic acids research.

Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.

J. Adamovicz, S. Little, W. Webster, 2010, Vaccine.

Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice.

J. Adamovicz, S. Little, W. Webster, 2008, Biologicals : journal of the International Association of Biological Standardization.

Enzootic plague reduces black-footed ferret (Mustela nigripes) survival in Montana.

M. Matchett, D. Biggins, T. Rocke, 2010, Vector borne and zoonotic diseases.

Inactivation and Extraction of Bacterial Spores for Systems Biological Analysis

R. Cybulski, B. Powell, 2011 .

Dendritic Cell Targeting Vaccines

Y. Do, B. Powell, 2015 .

Disrupting the luxS quorum sensing gene does not significantly affect Bacillus anthracis virulence in mice or guinea pigs

N. Vietri, J. Bozue, C. Cote, 2012, Virulence.

alleles.two temperature-sensitive dnaG Escherichia coli essential GTPase era that Characterization of mutations affecting the

J. Lupski, R. Britton, B. Powell, 2012 .

Characterization of mutations affecting the Escherichia coli essential GTPase era that suppress two temperature-sensitive dnaG alleles

J. Lupski, D. Court, R. Britton, 1997, Journal of bacteriology.

Isolation and preliminary characterization of the human and mouse homologues of the bacterial cell cycle gene era.

L. Shaffer, J. Lupski, D. Court, 2000, Genomics.

Cloning and Analysis of the rnc-era-recOOperon from Pseudomonas aeruginosa

D. Court, Yoshikazu Nakamura, B. Powell, 1999, Journal of bacteriology.

Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus).

J. Osorio, T. Rocke, B. Powell, 2010, Vector borne and zoonotic diseases.

Purification and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague.

G. P. Andrews, B. Powell, G. L. Coffman, 2011, Protein expression and purification.

Design and Testing for a Nontagged F1‐V Fusion Protein as Vaccine Antigen against Bubonic and Pneumonic Plague

Leonard A. Smith, J. K. Pullen, P. Worsham, 2005, Biotechnology progress.

Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes

A. Andrianov, P. C. Fusco, R. Chavan, 2015, Clinical and experimental vaccine research.

Purified Bacillus anthracis Lethal Toxin Complex Formed in Vitro and during Infection Exhibits Functional and Biological Activity*

J. Ezzell, T. Abshire, T. Hoover, 2005, Journal of Biological Chemistry.

Pressure cycling technology in systems biology.

Bradford S Powell, Alexander V Lazarev, Greta Carlson, 2012, Methods in molecular biology.

Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faecium

C. Merril, S. Adhya, B. Biswas, 2002, Infection and Immunity.

Molecular characterization of the vir regulon of Agrobacterium tumefaciens: complete nucleotide sequence and gene organization of the 28.63-kbp regulon cloned as a single unit.

K. Shirasu, C. Kado, E. Zyprian, 1990, Plasmid.

virG of Agrobacterium tumefaciens plasmid pTiC58 encodes a DNA‐binding protein

P. Rogowsky, B. Powell, C. I. Kado, 1989, Molecular microbiology.

Nucleotide sequence of the virG locus of the Agrobacterium tumefaciens plasmid pTiC58

R. O. Morris, C. Kado, P. Rogowsky, 1987, Molecular microbiology.

Characterization of the virA virulence gene of the nopaline plasmid, pTiC58, of Agrobacterium tumefaciens

C. Kado, P. Rogowsky, P. Morel, 1989, Molecular microbiology.

Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.

T. Hoover, B. Ivins, W. Johnson, 2006, Vaccine.

Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity

T. Hoover, G. P. Andrews, J. Adamovicz, 2007, Proteins.

[Demonstration of 3 functional domains responsible for a kinase activity in VirA, a transmembrane sensory protein encoded by the Ti plasmid of Agrobacterium tumefaciens].

C. Kado, P. Morel, B. Powell, 1990, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.

P. Clark, S. Giardina, D. Michiel, 2007, Protein expression and purification.

Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.

W. Swietnicki, B. Powell, Jeremy L. Goodin, 2005, Protein expression and purification.

Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum.

G. P. Andrews, B. Powell, G. L. Coffman, 2005, Protein expression and purification.

Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor.

R. Steinman, D. Perlin, A. Didierlaurent, 2012, Vaccine.

VACCINATION WITH F1-V FUSION PROTEIN PROTECTS BLACK-FOOTED FERRETS (MUSTELA NIGRIPES) AGAINST PLAGUE UPON ORAL CHALLENGE WITH YERSINIA PESTIS

T. Rocke, B. Powell, J. Kreeger, 2008, Journal of wildlife diseases.

Mapping Protective Epitopes for Anthrax and Plague Vaccine Antigens by LC-MS/MS

S. Little, T. Chanh, B. Powell, 2006 .

Structural Characterizations of Protein Antigens for The Next-Generation Vaccines Against Anthrax and Plague

J. Adamovicz, W. Ribot, B. Powell, 2004 .

Chlamydia pneumoniae Secretion of a Protease-Like Activity Factor for Degrading Host Cell Transcription Factors Required for Major Histocompatibility Complex Antigen Expression

C. Merril, S. Adhya, B. Biswas, 2002 .

lac Up-promoter mutants with increased homology to the consensus promoter sequence

M. Caruthers, W. Mandecki, B. Powell, 1985, Journal of bacteriology.

High-level expression of a gene encoding the human complement factor C5a in Escherichia coli.

G. Carter, J. L. Fox, K. Mollison, 1986, Gene.